EUVIMEDEUVIMED entdecken
Crossref

CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells

Mijin Park, Jin Hwa Cho, Byul Moon, Jeong-Hoon Kim, Jung-Ae Kim iD

Genes & Genomics · 2023

DOI: 10.1007/s13258-022-01351-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Genomics, 2023. Verfasst von Mijin Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Research Foundation, Ministry of Science and ICT, Republic of Korea, Korea Research Institute of Bioscience and Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Elevated expression of Dickkopf-1 (DKK1) is frequently observed in hepatocellular carcinoma (HCC) patients with poor clinical outcomes. Several reports indicating the functional involvement of DKK1 in HCC progression have suggested DKK1 as a promising therapeutic target for HCC. OBJECTIVE: In this study, to develop an efficient way to target DKK1, we assessed the effect of CDK9 inhibitors on DKK1 expression linked to metastatic movement of HCC. METHODS: The expression of DKK1 in CDK9 inhibitor-treated HCC cells was measured by western blot, ELISA and quantitative real-time reverse transcription PCR. Wound healing assay, migration assay, invasion assay and western blot were examined to evaluate the functional role of DKK1 in CDK9 inhibitors-treated HCC. RESULTS: Inactivation of CDK9 either by a catalytic inhibitor being clinically evaluated or by a specific CDK9 protein degrader largely downregulated DKK1 expression at the transcript and protein levels. In addition, CDK9 inhibitors suppressed the migration and invasion of HCC cells. We observed that ectopic high expression of DKK1 at least partially reversed the defects in metastatic movement of HCC cells mediated by CDK9 inhibitors. We further discovered that the DKK1-nuclear β-catenin axis associated with the metastatic potential of HCC cells was impaired by CDK9 inhibitors. CONCLUSION: Taken together, our findings suggest that CDK9 inhibitors are potent tools to target DKK1, which can suppress the metastatic progression of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansCell Line, TumorCell MovementIntercellular Signaling Peptides and ProteinsCyclin-Dependent Kinase 9

Stichwörter der Autor:innen

CDK9 inhibitorDKK1InvasionLiver cancerMigration

Substanzen

Intercellular Signaling Peptides and ProteinsCDK9 protein, humanCyclin-Dependent Kinase 9DKK1 protein, human

Autor:innen und Institutionen

  • Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
  • Department of Bioscience, University of Science and Technology, Daejeon, 34113, Republic of Korea.
  • Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
  • Department of Bioscience, University of Science and Technology, Daejeon, 34113, Republic of Korea. jhoonkim@kribb.re.kr.
  • Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea. jhoonkim@kribb.re.kr.
  • Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, Republic of Korea. jhoonkim@kribb.re.kr.

ORCID-Profile: Jung-Ae Kim

Förderung

  • National Research Foundation, Ministry of Science and ICT, Republic of Korea
  • Korea Research Institute of Bioscience and Biotechnology

Zitieren

APA

Park, M., Cho, J. H., Moon, B., Kim, J. H., & Kim, J. A. (2023). CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells. Genes & Genomics. https://doi.org/10.1007/s13258-022-01351-9

Vancouver

Park M, Cho JH, Moon B, Kim JH, Kim JA. CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells. Genes & Genomics. 2023. doi:10.1007/s13258-022-01351-9

BibTeX
@article{Park2023,
  author = {Park, Mijin and Cho, Jin Hwa and Moon, Byul and Kim, Jeong-Hoon and Kim, Jung-Ae},
  title = {CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells},
  journal = {Genes & Genomics},
  year = {2023},
  doi = {10.1007/s13258-022-01351-9}
}
Kostenlos starten →